DK3463281T3 - Beta-hårnåls peptidomimetic med elastase hæmmende aktivitet og aerosol doseringsformer heraf - Google Patents

Beta-hårnåls peptidomimetic med elastase hæmmende aktivitet og aerosol doseringsformer heraf Download PDF

Info

Publication number
DK3463281T3
DK3463281T3 DK17733738.3T DK17733738T DK3463281T3 DK 3463281 T3 DK3463281 T3 DK 3463281T3 DK 17733738 T DK17733738 T DK 17733738T DK 3463281 T3 DK3463281 T3 DK 3463281T3
Authority
DK
Denmark
Prior art keywords
dosage forms
inhibiting activity
aerosol dosage
beta hairpin
hairpin peptidomimetic
Prior art date
Application number
DK17733738.3T
Other languages
English (en)
Inventor
Piet Bruijnzeel
Johann Zimmermann
Philip Barth
Eric Chevalier
Christian Ludin
Manfred Keller
Original Assignee
Spexis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spexis Ag filed Critical Spexis Ag
Application granted granted Critical
Publication of DK3463281T3 publication Critical patent/DK3463281T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
DK17733738.3T 2016-05-31 2017-05-31 Beta-hårnåls peptidomimetic med elastase hæmmende aktivitet og aerosol doseringsformer heraf DK3463281T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16020210 2016-05-31
PCT/EP2017/025157 WO2017207118A1 (en) 2016-05-31 2017-05-31 Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof

Publications (1)

Publication Number Publication Date
DK3463281T3 true DK3463281T3 (da) 2022-09-26

Family

ID=56108445

Family Applications (2)

Application Number Title Priority Date Filing Date
DK17733738.3T DK3463281T3 (da) 2016-05-31 2017-05-31 Beta-hårnåls peptidomimetic med elastase hæmmende aktivitet og aerosol doseringsformer heraf
DK17733737.5T DK3463280T3 (da) 2016-05-31 2017-05-31 Beta-hårnåls peptidomimetic med elastase hæmmende aktivitet og aerosol doseringsformer heraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK17733737.5T DK3463280T3 (da) 2016-05-31 2017-05-31 Beta-hårnåls peptidomimetic med elastase hæmmende aktivitet og aerosol doseringsformer heraf

Country Status (26)

Country Link
US (3) US11235023B2 (da)
EP (2) EP3463281B1 (da)
JP (4) JP7286319B6 (da)
KR (2) KR102511284B1 (da)
CN (3) CN109310613A (da)
AU (2) AU2017273508B2 (da)
BR (2) BR112018074532B1 (da)
CA (2) CA3024522A1 (da)
CL (2) CL2018003391A1 (da)
DK (2) DK3463281T3 (da)
EA (2) EA039603B1 (da)
ES (2) ES2928050T3 (da)
HR (2) HRP20221185T1 (da)
HU (2) HUE060393T2 (da)
IL (2) IL263112B2 (da)
LT (2) LT3463280T (da)
MA (2) MA45168A (da)
MX (2) MX2018014752A (da)
PH (2) PH12018502522A1 (da)
PL (2) PL3463281T3 (da)
PT (2) PT3463281T (da)
RS (2) RS63622B1 (da)
SG (3) SG11201810137UA (da)
UA (2) UA125899C2 (da)
WO (2) WO2017207118A1 (da)
ZA (2) ZA201807772B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE060393T2 (hu) * 2016-05-31 2023-02-28 Spexis Ag Béta-hairpin peptidomimetikum elasztáz gátló hatással és annak aeroszolos adagolási formái
BR112022014861A2 (pt) * 2020-01-30 2022-09-20 Vertex Pharma Métodos de tratamento para deficiência de alfa-1 antittripsina
MX2023005982A (es) * 2020-11-23 2023-08-15 Spexis Ag Composiciones de un peptidomimetico de horquilla beta y formas de dosificacion en aerosol del mismo.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69718047T2 (de) * 1996-11-01 2003-11-13 Xoma Technology Ltd Therapeutische verwendung von bpi proteineprodukten bei patienten mit zystischer fibrose
AU2006206272A1 (en) * 2005-01-21 2006-07-27 Alza Corporation Therapeutic peptide formulations for coating microneedles with improved stabitity containing at least one counterion
KR101420198B1 (ko) * 2005-02-17 2014-08-13 폴리포 리미티드 프로테아제 저해 활성을 가지는 주형-고정된 β-헤어핀 구조의 펩티드모방체
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
DK1981572T3 (da) 2006-02-09 2013-03-04 Pari Pharma Gmbh Pulmonal afgivelse af alfa-1-proteinaseinhibitor
LT1991201T (lt) * 2006-02-10 2018-07-25 Pari Pharma Gmbh Puškiami antibiotikai inhaliaciniam gydymui
WO2008025560A1 (en) 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
EP1927373B1 (en) * 2006-11-30 2012-08-22 PARI Pharma GmbH Inhalation nebulizer
ES2532667T3 (es) 2011-09-12 2015-03-30 Meiji Seika Pharma Co., Ltd. Composiciones acuosas que contienen arbekacina
WO2015096672A1 (zh) 2013-12-23 2015-07-02 石家庄铁道大学 测试装置
JP6431486B2 (ja) 2013-12-26 2018-11-28 株式会社カネカ 太陽電池のi‐v測定方法、太陽電池のi‐v測定装置、太陽電池の製造方法、太陽電池モジュールの製造方法、および太陽電池モジュール
SI3087094T1 (sl) * 2013-12-27 2022-11-30 Spexis Ag BETA-lasnični peptidomimetiki kot selektivni zaviralci elastaze
EA034910B1 (ru) 2013-12-27 2020-04-06 Полифор Аг Бета-шпилечные пептидомиметики в качестве селективных ингибиторов эластазы
HUE060393T2 (hu) * 2016-05-31 2023-02-28 Spexis Ag Béta-hairpin peptidomimetikum elasztáz gátló hatással és annak aeroszolos adagolási formái

Also Published As

Publication number Publication date
KR20190015309A (ko) 2019-02-13
US11235023B2 (en) 2022-02-01
RS63639B1 (sr) 2022-10-31
EA201892819A1 (ru) 2019-05-31
BR112018074532A2 (pt) 2019-03-19
LT3463281T (lt) 2022-09-26
US11235024B2 (en) 2022-02-01
UA125900C2 (uk) 2022-07-06
EP3463280B1 (en) 2022-07-06
EA039603B1 (ru) 2022-02-16
EP3463281B1 (en) 2022-07-06
HRP20221185T1 (hr) 2022-12-09
CN109310613A (zh) 2019-02-05
CA3024521C (en) 2023-06-20
US11844823B2 (en) 2023-12-19
JP2023017793A (ja) 2023-02-07
CL2018003390A1 (es) 2019-05-03
IL263114A (en) 2018-12-31
KR102511284B1 (ko) 2023-03-16
MX2018014425A (es) 2019-03-28
PH12018502521A1 (en) 2019-10-21
US20200230203A1 (en) 2020-07-23
HUE060119T2 (hu) 2023-02-28
CL2018003391A1 (es) 2019-05-03
MX2018014752A (es) 2019-04-25
SG10202113280XA (en) 2021-12-30
CA3024522A1 (en) 2017-12-07
SG11201810137UA (en) 2018-12-28
UA125899C2 (uk) 2022-07-06
MA45167A (fr) 2019-04-10
EA201892818A1 (ru) 2019-05-31
HRP20221194T1 (hr) 2022-12-09
AU2017273507A1 (en) 2018-12-13
EP3463281A1 (en) 2019-04-10
KR20190011750A (ko) 2019-02-07
WO2017207118A1 (en) 2017-12-07
BR112018074532B1 (pt) 2022-02-08
RS63622B1 (sr) 2022-10-31
CN116159024A (zh) 2023-05-26
DK3463280T3 (da) 2022-09-26
JP2019523763A (ja) 2019-08-29
AU2017273507B2 (en) 2022-03-17
US20200230202A1 (en) 2020-07-23
WO2017207117A1 (en) 2017-12-07
MA45168A (fr) 2019-04-10
PL3463280T3 (pl) 2022-11-07
JP7286319B6 (ja) 2023-06-16
HUE060393T2 (hu) 2023-02-28
IL263114B2 (en) 2023-12-01
EP3463280A1 (en) 2019-04-10
PT3463280T (pt) 2022-10-07
PT3463281T (pt) 2022-10-07
JP7286319B2 (ja) 2023-06-05
CA3024521A1 (en) 2017-12-07
ES2927948T3 (es) 2022-11-14
AU2017273508B2 (en) 2022-07-28
IL263112B1 (en) 2023-06-01
SG11201810138XA (en) 2018-12-28
IL263114B1 (en) 2023-08-01
BR112018074551A2 (pt) 2019-03-06
IL263112A (en) 2018-12-31
PH12018502522A1 (en) 2019-10-21
JP2022078013A (ja) 2022-05-24
LT3463280T (lt) 2022-09-26
ZA201807772B (en) 2022-10-26
US20220023379A1 (en) 2022-01-27
AU2017273508A1 (en) 2018-12-13
CN109195580A (zh) 2019-01-11
KR102480800B1 (ko) 2022-12-22
BR112018074551B1 (pt) 2022-02-08
PL3463281T3 (pl) 2022-11-07
ES2928050T3 (es) 2022-11-15
IL263112B2 (en) 2023-10-01
JP2019523222A (ja) 2019-08-22
ZA201807773B (en) 2022-07-27

Similar Documents

Publication Publication Date Title
NL301217I2 (nl) tirzepatide en farmaceutisch aanvaardbare zouten daarvan
DK3380101T3 (da) Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
DK3319611T3 (da) Oxysteroler og fremgangsmåder til anvendelse deraf
DK3319612T3 (da) Oxysteroler og fremgansmåder til anvendelse derfor
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
DK3514153T3 (da) Pyrimidinforbindelse og farmaceutisk anvendelse deraf
FR3031807B1 (fr) Senseur stellaire diurne et nocturne a polarisateur actif
DK3468642T3 (da) Doseringsapparat og injektionsanordning
DK3474844T3 (da) Doseringsform til fordampning og rygning
MA49905A (fr) Polyesteramines et polyesterquats
HK1248209A1 (zh) 尿素衍生物和其用途
IL260193A (en) Tlr inhibitory oligonucleotides and their use
DK3328368T3 (da) Forbindelser og farmaceutisk sammensætning associeret med ubiquitinering-proteasomsystem
DK3463281T3 (da) Beta-hårnåls peptidomimetic med elastase hæmmende aktivitet og aerosol doseringsformer heraf
KR102135648B9 (ko) 항독성 또는 항병원성 활성을 갖는 레오이딘 화합물 및 이의 용도
DK3321279T3 (da) Exenatidmodificeringsmiddel og anvendelse deraf
DK3374468T3 (da) Flamme- eller brandhæmmende midler og fremstilling og anvendelse deraf
DK3313999T3 (da) Polypeptider med demethyleringsaktivitet
DK3263133T3 (da) Pyridinonforbindelse og anvendelse deraf
DK3215143T3 (da) Kombination omfattende spirulina og palmitoylethanolamid
HK1249011A1 (zh) 包括線粒體分裂抑制肽的治療組合物、其變體及這些的使用方法
DK3438118T3 (da) Peptidderivat og anvendelse deraf
PL3307080T3 (pl) Środek słodzący oraz jego zastosowanie
IL274353A (en) Heterocyclic inhibitors of mitochondrial activity and their uses